SPYRE THERAPEUTICS, INC.: cash_and_equivalents

Value{"amount": 35243000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2023-03-31)
Statuscurrent
EntitySPYRE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-020825 · Open the official SEC filing →
Retrieved: 2026-08-19T16:49:38.245373+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001636282/cash-and-equivalents/2023-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/23956aaf-0eb6-4e19-9b5c-1f4c0d9ba4cd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies